Memorial Sloan Kettering Cancer Center
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Looking at Cognitive and Brain Changes in People With Lymphoma Receiving CAR-T Therapy
- Conditions
- Lymphoma Receiving CAR-T Therapy
- Interventions
- Behavioral: neurocognitive evaluationsDiagnostic Test: brain MRIsOther: Blood samples
- First Posted Date
- 2019-09-27
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 120
- Registration Number
- NCT04107285
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
A Study of the Experience of Music Therapy in Cancer Patients With Delirium
- Conditions
- Cancer Patients With Delirium
- Interventions
- Behavioral: Music therapyBehavioral: Interviews
- First Posted Date
- 2019-09-26
- Last Posted Date
- 2023-08-22
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT04104217
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
- Conditions
- Hematologic Malignancies
- Interventions
- Drug: Antithymocyte globulin (ATG)Procedure: Allogeneic hematopoietic cell transplantation (Allo-HCT)
- First Posted Date
- 2019-09-23
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 39
- Registration Number
- NCT04098393
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Integrative Medicine for Pain in Patients With Advanced Cancer Trial (IMPACT)
- Conditions
- Cancer Pain
- Interventions
- Procedure: MassageProcedure: Acupuncture
- First Posted Date
- 2019-09-19
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 300
- Registration Number
- NCT04095234
- Locations
- πΊπΈ
Baptist Alliance MCI, Miami, Florida, United States
πΊπΈMemorial Sloan Kettering Commack (All Protocol Activities), Commack, New York, United States
πΊπΈMemorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma
- Conditions
- Desmoplastic Small Round Cell TumorRhabdomyosarcoma
- Interventions
- First Posted Date
- 2019-09-19
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 21
- Registration Number
- NCT04095221
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- Conditions
- Invasive Ductal Carcinoma, BreastDCIS Grade 2DCISBreast CancerInvasive Ductal Breast CarcinomaDCIS Grade 1
- Interventions
- Radiation: Accelerated Partial Breast Irradiation
- First Posted Date
- 2019-09-10
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 280
- Registration Number
- NCT04084730
- Locations
- πΊπΈ
Norwalk Hospital, Norwalk, Connecticut, United States
πΊπΈBaptist Alliance Miami Cancer Institute, Miami, Florida, United States
πΊπΈMemorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma
- Conditions
- Metastatic Renal Cell CarcinomaSuccinate Dehydrogenase Deficient Renal Cell CarcinomaFumarate Hydratase Deficient Renal Cell Carcinoma
- Interventions
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 18
- Registration Number
- NCT04068831
- Locations
- πΊπΈ
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
πΊπΈMemorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
πΊπΈMemorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
Study of the Imaging Agent 18F-Var3 in Patients With Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Diagnostic Test: F-Var3 PET/CTOther: Blood draw
- First Posted Date
- 2019-08-13
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 6
- Registration Number
- NCT04054986
- Locations
- πΊπΈ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study
- Conditions
- Adnexal MassOvarian Cancer
- First Posted Date
- 2019-08-09
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 48
- Registration Number
- NCT04051502
- Locations
- πΊπΈ
Memorial Sloan Kettering Bergen (Consent only ), Montvale, New Jersey, United States
πΊπΈMemorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
πΊπΈMemorial Sloan Kettering Monmouth (Consent only), Middletown, New Jersey, United States
Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
- Conditions
- Pituitary TumorPituitaryPituitary CarcinomaPituitary Cancer
- Interventions
- First Posted Date
- 2019-08-02
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 9
- Registration Number
- NCT04042753
- Locations
- πΊπΈ
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
πΊπΈMemorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
πΊπΈMemorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States